thyroxine has been researched along with Cancer of Mouth in 5 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thyroid function was measured by means of thyroid stimulating hormone (TSH), free thyroxine (FT4) and free triiodthyronine (FT3) in 43 patients who had nonthyroid head-neck carcinomas treated by radiotherapy or radiotherapy in combination with other modalities." | 3.80 | Hypothyroidism after radiotherapy of head and neck cancer. ( Bernát, L; Hrušák, D, 2014) |
| "Onset of hypothyroidism was zero to six months, with transient loss of thyroid reserve occurring up to 18 months." | 1.25 | Thyroid function after radiation and surgery for head and neck cancer. ( Kuisk, H; Nuttall, FQ; Pollak, K; Shafer, RB, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Su, KW | 3 |
| Lin, HY | 3 |
| Chiu, HC | 2 |
| Shen, SY | 1 |
| ChangOu, CA | 2 |
| Crawford, DR | 2 |
| Yang, YSH | 2 |
| Shih, YJ | 3 |
| Li, ZL | 2 |
| Huang, HM | 1 |
| Whang-Peng, J | 3 |
| Ho, Y | 3 |
| Wang, K | 3 |
| Wu, CY | 1 |
| Chin, YT | 2 |
| Pan, YS | 1 |
| Huang, TY | 1 |
| Su, PY | 1 |
| Lee, SY | 2 |
| Chen, YR | 2 |
| Mousa, SA | 1 |
| Davis, PJ | 2 |
| Lin, SJ | 1 |
| Chou, SY | 1 |
| Sh Yang, YC | 1 |
| Nana, AW | 1 |
| Lim, YT | 1 |
| Fu, E | 1 |
| Bernát, L | 1 |
| Hrušák, D | 1 |
| Shafer, RB | 1 |
| Nuttall, FQ | 1 |
| Pollak, K | 1 |
| Kuisk, H | 1 |
5 other studies available for thyroxine and Cancer of Mouth
| Article | Year |
|---|---|
Thyroid Hormone Induces Oral Cancer Growth via the PD-L1-Dependent Signaling Pathway.
Topics: B7-H1 Antigen; beta Catenin; Humans; Integrin alphaVbeta3; Mouth Neoplasms; Nuclear Proteins; RNA, S | 2022 |
NDAT suppresses pro-inflammatory gene expression to enhance resveratrol-induced anti-proliferation in oral cancer cells.
Topics: B7-H1 Antigen; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclooxygenase 2; Drug Synergism; Ge | 2020 |
Nano-diamino-tetrac (NDAT) inhibits PD-L1 expression which is essential for proliferation in oral cancer cells.
Topics: Antineoplastic Agents; B7-H1 Antigen; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation | 2018 |
Hypothyroidism after radiotherapy of head and neck cancer.
Topics: Aged; Carcinoma; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Female; Follow-Up Studies; | 2014 |
Thyroid function after radiation and surgery for head and neck cancer.
Topics: Aged; Cobalt Radioisotopes; Follow-Up Studies; Humans; Hypothyroidism; Laryngeal Neoplasms; Middle A | 1975 |